You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Harvard Business School
McKinsey
Medtronic
Dow

Last Updated: November 28, 2023

XYOSTED (AUTOINJECTOR) Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Xyosted (autoinjector) patents expire, and what generic alternatives are available?

Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. There are twenty-one patents protecting this drug.

This drug has eighty-nine patent family members in fourteen countries.

The generic ingredient in XYOSTED (AUTOINJECTOR) is testosterone enanthate. There are sixty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the testosterone enanthate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Xyosted (autoinjector)

A generic version of XYOSTED (AUTOINJECTOR) was approved as testosterone enanthate by WATSON PHARMS INC on December 31st, 1969.

  Try a Trial

US Patents and Regulatory Information for XYOSTED (AUTOINJECTOR)

XYOSTED (AUTOINJECTOR) is protected by twenty-one US patents.

Patents protecting XYOSTED (AUTOINJECTOR)

Needle assisted jet injection administration of testosterone compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Injection device with cammed RAM assembly
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Needle assisted jet injection device having reduced trigger force
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Prefilled syringe injector
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Testosterone ester triglyceride formulations
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Needle assisted jet injection administration of testosterone compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Needle assisted injection device having reduced trigger force
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Injection device with cammed ram assembly
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Needle assisted injection administration of testosterone compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Hematocrit modulation through needle assisted jet injection of testosterone
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Syringe shock absorber for use in an injection device
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial


Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Prefilled syringe injector
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial


Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Prefilled syringe jet injector
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Prefilled syringe jet injector
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Prefilled syringe jet injector
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Prefilled syringe jet injector
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Prefilled syringe jet injector
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Needle assisted jet injection device having reduced trigger force
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Needle assisted jet injection administration of testosterone compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-002 Sep 28, 2018 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-002 Sep 28, 2018 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for XYOSTED (AUTOINJECTOR)

International Patents for XYOSTED (AUTOINJECTOR)

See the table below for patents covering XYOSTED (AUTOINJECTOR) around the world.

Country Patent Number Title Estimated Expiration
Japan 2019058744 テストステロン組成物の針支援式ジェット注入投与 (NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONS) ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 2015054213 ⤷  Try a Trial
South Korea 20070117543 PREFILLED NEEDLE ASSISTED JET INJECTOR ⤷  Try a Trial
European Patent Office 3653213 MODULATION DE L'HÉMATOCRITE PAR L'INTERMÉDIAIRE D'UNE INJECTION À JET DE TESTOSTÉRONE ASSISTÉE PAR AIGUILLE (HEMATOCRIT MODULATION THROUGH NEEDLE ASSISTED JET INJECTION OF TESTOSTERONE) ⤷  Try a Trial
Japan 2023052550 テストステロン組成物の針に補助されるジェット注射投与 ⤷  Try a Trial
Japan 7150926 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Moodys
Mallinckrodt
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.